1370 related articles for article (PubMed ID: 9785148)
21. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
Parnetti L; Lowenthal DT; Presciutti O; Pelliccioli GP; Palumbo R; Gobbi G; Chiarini P; Palumbo B; Tarducci R; Senin U
J Am Geriatr Soc; 1996 Feb; 44(2):133-8. PubMed ID: 8576501
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
McNeill R; Sare GM; Manoharan M; Testa HJ; Mann DM; Neary D; Snowden JS; Varma AR
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):350-5. PubMed ID: 17158559
[TBL] [Abstract][Full Text] [Related]
23. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
24. Clinical-neuropathological correlations in Alzheimer's disease and related dementias.
Galasko D; Hansen LA; Katzman R; Wiederholt W; Masliah E; Terry R; Hill LR; Lessin P; Thal LJ
Arch Neurol; 1994 Sep; 51(9):888-95. PubMed ID: 8080388
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
26. CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular dementia, depression and paraphrenia.
Denihan A; Wilson G; Cunningham C; Coakley D; Lawlor BA
Int J Geriatr Psychiatry; 2000 Apr; 15(4):306-12. PubMed ID: 10767729
[TBL] [Abstract][Full Text] [Related]
27. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
[TBL] [Abstract][Full Text] [Related]
28. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
[TBL] [Abstract][Full Text] [Related]
29. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
[TBL] [Abstract][Full Text] [Related]
31. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
[TBL] [Abstract][Full Text] [Related]
32. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
Scheltens P; Korf ES
Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
[TBL] [Abstract][Full Text] [Related]
33. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.
Nitrini R; Buchpiguel CA; Caramelli P; Bahia VS; Mathias SC; Nascimento CM; Degenszajn J; Caixeta L
Acta Neurol Scand; 2000 Mar; 101(3):172-6. PubMed ID: 10705939
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
[TBL] [Abstract][Full Text] [Related]
35. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia.
Kemp PM; Hoffmann SA; Holmes C; Bolt L; Ward T; Holmes RB; Fleming JS
Nucl Med Commun; 2005 Dec; 26(12):1099-106. PubMed ID: 16264357
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
37. Medial temporal lobe width on CT scanning in Alzheimer's disease: comparison with vascular dementia, depression and dementia with Lewy bodies.
O'Brien JT; Metcalfe S; Swann A; Hobson J; Jobst K; Ballard C; McKeith I; Gholkar A
Dement Geriatr Cogn Disord; 2000; 11(2):114-8. PubMed ID: 10705169
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
39. Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease.
Waldemar G; Høgh P; Paulson OB
Int Psychogeriatr; 1997; 9 Suppl 1():223-7; discussion 247-52. PubMed ID: 9447443
[TBL] [Abstract][Full Text] [Related]
40. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography.
Jobst KA; Smith AD; Szatmari M; Molyneux A; Esiri ME; King E; Smith A; Jaskowski A; McDonald B; Wald N
Lancet; 1992 Nov; 340(8829):1179-83. PubMed ID: 1359259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
